A detailed history of Forum Financial Management, LP transactions in Pfizer Inc stock. As of the latest transaction made, Forum Financial Management, LP holds 61,644 shares of PFE stock, worth $1.65 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
61,644
Previous 65,561 5.97%
Holding current value
$1.65 Million
Previous $1.83 Million 2.78%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$27.7 - $31.39 $108,500 - $122,954
-3,917 Reduced 5.97%
61,644 $1.78 Million
Q2 2024

Jul 30, 2024

BUY
$25.26 - $29.6 $207,611 - $243,282
8,219 Added 14.33%
65,561 $1.83 Million
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $26,744 - $30,711
1,033 Added 1.83%
57,342 $1.59 Million
Q4 2023

Feb 07, 2024

SELL
$26.13 - $33.94 $124,248 - $161,384
-4,755 Reduced 7.79%
56,309 $1.62 Million
Q3 2023

Nov 03, 2023

SELL
$32.09 - $37.51 $9,049 - $10,577
-282 Reduced 0.46%
61,064 $2.03 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $248,650 - $287,682
6,884 Added 12.64%
61,346 $2.25 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $2,954 - $3,846
-75 Reduced 0.14%
54,462 $2.22 Million
Q4 2022

Jan 24, 2023

SELL
$41.75 - $54.5 $66,925 - $87,363
-1,603 Reduced 2.86%
54,537 $0
Q3 2022

Nov 07, 2022

SELL
$43.76 - $53.42 $737,137 - $899,859
-16,845 Reduced 23.08%
56,140 $2.46 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $295,418 - $350,274
6,349 Added 9.53%
72,985 $3.83 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $82,578 - $102,325
1,805 Added 2.78%
66,636 $3.45 Million
Q4 2021

Feb 18, 2022

BUY
$41.32 - $61.25 $2.68 Million - $3.97 Million
64,831 New
64,831 $3.83 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Forum Financial Management, LP Portfolio

Follow Forum Financial Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forum Financial Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Forum Financial Management, LP with notifications on news.